StockData

BioScience Health Innovations, Inc. (BHIC) stock

BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.78+0.00 (0.00%)

Close on Oct 16, 2026Market cap $79.22MP/E –Yield –

BioScience Health Innovations operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

BioScience Health Innovations's operating income for the twelve months ending Jun 30, 2026 was -$613.24K, down 164.5% year over year. For fiscal 2025 it was $719.05K, up 726.5% from the year before. The highest annual figure on record is $719.05K in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$719.05K+726.5%
FY2024Dec 31, 2024$87.00K–
FY2022Aug 31, 2022-$91.92K–
FY2021Aug 31, 2021-$25.61K–
FY2020Aug 31, 2020-$7.68K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$217.88K-147.6%
Q1 FY2026CQ1 2026Mar 31, 2026-$229.91K-153.9%
Q4 FY2025CQ4 2025Dec 31, 2025-$156.67K-1673.5%
Q3 FY2025CQ3 2025Sep 30, 2025-$8.78K-115.6%
Q2 FY2025CQ2 2025Jun 30, 2025$457.70K+516.7%
Q1 FY2025CQ1 2025Mar 31, 2025$426.80K–
Q4 FY2024CQ4 2024Dec 31, 2024$9.96K–
Q3 FY2024CQ3 2024Sep 30, 2024$56.20K–
Q2 FY2024CQ2 2024Jun 30, 2024$74.22K–
Q1 FY2024CQ1 2024Mar 31, 2024-$53.38K–
Q4 FY2022CQ3 2022Aug 31, 2022-$3.71K–
Q3 FY2022CQ2 2022May 31, 2022-$47.88K–
Q2 FY2022CQ1 2022Feb 28, 2022-$26.24K–
Q1 FY2022CQ4 2021Nov 30, 2021-$14.09K–
Q4 FY2021CQ3 2021Aug 31, 2021-$4.16K–
Q3 FY2021CQ2 2021May 31, 2021-$3.21K–
Q2 FY2021CQ1 2021Feb 28, 2021-$12.67K–
Q1 FY2021CQ4 2020Nov 30, 2020-$5.58K–
Q4 FY2020CQ3 2020Aug 31, 2020-$2.90K–
Q3 FY2020CQ2 2020May 31, 2020-$2.86K–
Q2 FY2020CQ1 2020Feb 29, 2020-$1.93K–
Q1 FY2020CQ4 2019Nov 30, 2019$0–

More BioScience Health Innovations figures

See a number that looks wrong?